Martin Lind
@martin.wsocial.eu
Entrepreneur and investor focused on sustainability, technology, science, and long-term value creation.
New episode of Market Signal now available. biostock.se/en/2026/07/b...
Between China, Wall Street and Nasdaq Stockholm | Market Signal #4
We begin with Jonathan Gertler, founder and CEO of Back Bay Life Science Advisors, who shares his view on the current global state of the sector. He analyzes the trends driving IPOs and capital raisin...
biostock.se
Many reach out to me saying that BioVal sets a new standard for life science analysis. They are wrong. BioVal is built on industry standards, it is just new to the Scandinavian stock market. biostock.se/en/2026/07/b...
BioVal™ analysis: Alzinova' ALZ-101 valued at SEK 7.1B
biostock.se
Great meeting today with W and our advisor @christopheleclercq.wsocial.eu as we plan our upcoming Brussels office. Europe, here we come 🇪🇺 Berlin and Paris next... @anna.wsocial.eu @sundstrand.wsocial.eu @johannesluiga.wsocial.eu
Premiere: Market Signal Guests in this premiere program: Adam Kostyal, President of Nasdaq. Andreas Lindblom (Sciety), Susanna Francke Rodau (Segulah Medical Acceleration), Bita Sehat (Trill Impact), Bita Sehat (Trill Impact), Ted Fjällman (Flerie) and Daniel Bolanowski (Arctic Asset).
Premiere: Market Signal – BioStock's new program initiative
We begin the premiere episode by delving into the agreement between SAGA Diagnostics and Roche company Foundation Medicine together with investors Andreas Lindblom (Sciety) and Susanna Francke Rodau (...
biostock.se
Global Forum 2026 This May, our premier event returns, dramatically expanded yet carefully curated to ensure a high-value experience. We continue to grow while keeping the intimate, connected feeling that makes our event a stellar experience. biostock.se/en/event/glo...
Global Forum 2026
biostock.se
State of Nordic Biopharma | Q1 2026 "A quarter defined by Novo Nordisk's turbulence" Full report for free at BioStock biostock.se/en/2026/04/s...
State of Nordic Biopharma | Q1 2026
Free quarterly report covering Nordic biotech, pharma and biopharma. Index performance, capital markets, catalyst calendar, and sector themes.
biostock.se
TFS HealthScience on the EU's new regulatory landscape. The regulatory landscape in Europe is currently undergoing major changes. BioStock invited Mesfin James, Vice President and Head of Regulatory at TFS HealthScience. biostock.se/en/2026/04/t...
TFS HealthScience on the EU's new regulatory landscape
See the whole programme below.
biostock.se
Today is National Banjo Day. Never could have happened without the mighty Earl Scruggs.
Public narrative is one layer. Execution is another. Platforms don’t succeed because of visibility. They succeed because of internal clarity. This is about what happens beyond the stage lights. #Execution #TechLeadership #Europe Join the waitlist: wsocial.eu
President Donald Trump capitulates to Iran, and the world's stock markets rejoice and surge. What has the free world gained from this conflict?
With Trump in the White House you don't need an investment advisor or fundamental analysis — all you need is a psychologist.
Första inlägget på W. Ska bli väldigt spännande att följa utvecklingen för W framåt.
